Nuvation Bio

NUVB59

Penny Stock

$3.11arrow_drop_up2.13%$0.06

Penny Stock

NUVB59

$3.11

arrow_drop_up2.13%$0.06

Penny Stock

Performance History

Key Stats
Open	$3.08
Prev. Close	$3.05
EPS	-2.22
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$1.02B
PE Ratio	-

	LOW	HIGH
Day Range	2.99	3.14
52 Week Range	0.95	4.16

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-2.22

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Nuvation Bio (NUVB)

Nuvation Bio Inc. (NUVB) is a biotechnology company focused on developing and commercializing novel therapies for the treatment of cancer and other life-threatening diseases. The company's mission is to improve patient outcomes by harnessing the power of the immune system to fight disease. Nuvation Bio's lead product candidate is NUV-422, a first-in-class antibody drug conjugate (ADC) targeting CD47, a protein overexpressed on many types of cancer cells. CD47 acts as a 'do not eat' signal to the immune system, allowing cancer cells to evade detection and destruction. By inhibiting CD47, NUV-422 enhances the ability of the immune system to recognize and eliminate cancer cells.

Nuvation Bio's smart analysis of the market suggests that there is a significant unmet need for new therapies in the field of oncology. With an aging population and increasing incidence of cancer, the demand for effective treatments is expected to continue growing. Nuvation Bio's innovative approach to targeting CD47 has the potential to address this need and transform the treatment landscape for cancer patients. The company's strong financial position and experienced management team position it well for success in the market.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. David T. Hung M.D.
Headquarters: New York
Employees: 54
Exchange: NYSE

Keep an eye on Nuvation Bio

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Nuvation Bio's (NUVB) price per share?

The current price per share for Nuvation Bio (NUVB) is $3.1. The stock has seen a price change of $0.05 recently, indicating a 1.64% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Nuvation Bio (NUVB)?

For Nuvation Bio (NUVB), the 52-week high is $4.16, which is 34.19% from the current price. The 52-week low is $0.95, the current price is 226.32% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Nuvation Bio (NUVB) a growth stock?

Nuvation Bio (NUVB) has shown an average price growth of 0.41% over the past three years. It has received a score of 27 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Nuvation Bio as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Nuvation Bio (NUVB) stock price performance year to date (YTD)?

As of the latest data, Nuvation Bio (NUVB) has a year-to-date price change of 97.45%. Over the past month, the stock has experienced a price change of 12.73%. Over the last three months, the change has been 5.8%. Over the past six months, the figure is 35.96%.

help

Is Nuvation Bio (NUVB) a profitable company?

Nuvation Bio (NUVB) has a net income of -$75.8M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -32.78K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$99.82M. Furthermore, the EBITDA is -$537.34M.

help

What is the market capitalization of Nuvation Bio (NUVB)?

Nuvation Bio (NUVB) has a market capitalization of $1.02B. The average daily trading volume is 1.45M, indicating the stock's liquidity and investor engagement.